• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $LVGO

    Livongo Health, Inc.

    Subscribe to $LVGO
    $LVGO
    Computer Software: Programming, Data Processing
    Technology

    IPO Year: 2019

    Exchange: NASDAQ

    Recent Analyst Ratings for Livongo Health, Inc.

    DatePrice TargetRatingAnalyst
    See more ratings

    Livongo Health, Inc. Press Releases

    Fastest customizable press release news feed in the world

    View All

    Define Ventures Appoints Carolyn Magill as Venture Partner

    The former Aetion and Remedy Partners CEO joins Define to further drive innovation across provider, payer, and pharmaceutical sectors SAN FRANCISCO, March 11, 2025 /PRNewswire/ -- Define Ventures, one of the largest venture capital firms focused on early-stage health tech companies, today announced that Carolyn Magill, former CEO of Aetion, has joined the firm as venture partner. Magill, leveraging her 25 years of invaluable experience scaling companies and fostering innovation within payer, provider, and pharmaceutical organizations, will partner with Define founders to scale their companies and become category-defining companies.

    3/11/25 5:30:00 AM ET
    $EVH
    $HIMS
    $LVGO
    Other Consumer Services
    Consumer Discretionary
    Medical/Nursing Services
    Health Care

    Mendaera Closes $73M Series B Financing to Scale Robotics and AI Across Mainstream Medical Procedures

    With its first-of-its-kind platform, Mendaera is pioneering a new category in medical robotics Mendaera, Inc., a Silicon Valley-based healthcare technology company developing a handheld robotic interventional platform, announced today the close of $73 million in Series B funding led by Threshold Ventures, with participation from investors including Lux Capital, PFM Health Sciences, and Fred Moll (founder of Intuitive Surgical and Auris Health). The financing will further Mendaera's efforts to scale robotics and AI across mainstream medical procedures. The healthcare system is facing an increasing supply and demand crisis, where the ability to consistently deliver high-quality care to pati

    9/26/24 6:05:00 AM ET
    $DOCS
    $RELY
    $LVGO
    EDP Services
    Technology
    Business Services
    Consumer Discretionary

    Salvo Health Secures $10.5 Million in Seed Funding To Scale Virtual Health Clinic for Chronic Conditions

    The virtual health clinic has launched to serve 60M+ Americans suffering from GI issues Salvo Health (https://www.salvohealth.com/), the virtual health clinic focusing on specialty care for chronic gut conditions, today announced the close of a $10.5 million seed funding investment led by Threshold Ventures along with Torch Capital and Felicis. These investors were early backers of healthcare innovators such as Livongo, Ro, and Brightline. Additional seed investors include founders from health transformers such as Ginger and Forward Health. Salvo Health is the first digital healthcare clinic delivering comprehensive and continuous gastro care. Members have unlimited messaging access to a

    8/9/22 9:00:00 AM ET
    $DOCS
    $RELY
    $LVGO
    EDP Services
    Technology
    Business Services
    Consumer Discretionary

    Livongo Health, Inc. Leadership Updates

    Live Leadership Updates

    View All

    Define Ventures Appoints Carolyn Magill as Venture Partner

    The former Aetion and Remedy Partners CEO joins Define to further drive innovation across provider, payer, and pharmaceutical sectors SAN FRANCISCO, March 11, 2025 /PRNewswire/ -- Define Ventures, one of the largest venture capital firms focused on early-stage health tech companies, today announced that Carolyn Magill, former CEO of Aetion, has joined the firm as venture partner. Magill, leveraging her 25 years of invaluable experience scaling companies and fostering innovation within payer, provider, and pharmaceutical organizations, will partner with Define founders to scale their companies and become category-defining companies.

    3/11/25 5:30:00 AM ET
    $EVH
    $HIMS
    $LVGO
    Other Consumer Services
    Consumer Discretionary
    Medical/Nursing Services
    Health Care

    Mendaera Closes $73M Series B Financing to Scale Robotics and AI Across Mainstream Medical Procedures

    With its first-of-its-kind platform, Mendaera is pioneering a new category in medical robotics Mendaera, Inc., a Silicon Valley-based healthcare technology company developing a handheld robotic interventional platform, announced today the close of $73 million in Series B funding led by Threshold Ventures, with participation from investors including Lux Capital, PFM Health Sciences, and Fred Moll (founder of Intuitive Surgical and Auris Health). The financing will further Mendaera's efforts to scale robotics and AI across mainstream medical procedures. The healthcare system is facing an increasing supply and demand crisis, where the ability to consistently deliver high-quality care to pati

    9/26/24 6:05:00 AM ET
    $DOCS
    $RELY
    $LVGO
    EDP Services
    Technology
    Business Services
    Consumer Discretionary